Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,410 | 257 | 98.9% |
| Education | $58.35 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,758 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $872.61 | 54 | $0 (2024) |
| GENZYME CORPORATION | $424.25 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $422.91 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $311.48 | 20 | $0 (2024) |
| Mylan Specialty L.P. | $255.26 | 13 | $0 (2024) |
| United Therapeutics Corporation | $181.58 | 8 | $0 (2024) |
| Genentech USA, Inc. | $157.87 | 8 | $0 (2024) |
| Amgen Inc. | $145.21 | 6 | $0 (2024) |
| PFIZER INC. | $135.44 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,507 | 106 | AstraZeneca Pharmaceuticals LP ($841.35) |
| 2023 | $1,941 | 94 | AstraZeneca Pharmaceuticals LP ($692.78) |
| 2022 | $292.12 | 15 | AstraZeneca Pharmaceuticals LP ($81.16) |
| 2021 | $20.08 | 1 | PFIZER INC. ($20.08) |
| 2020 | $10.08 | 1 | Vapotherm Inc ($10.08) |
| 2019 | $151.56 | 9 | AstraZeneca Pharmaceuticals LP ($67.92) |
| 2018 | $255.47 | 17 | GlaxoSmithKline, LLC. ($114.63) |
| 2017 | $291.19 | 16 | Boehringer Ingelheim Pharmaceuticals, Inc. ($83.66) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: VACCINES | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: Immunology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $31.62 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 797 | 1,148 | $349,599 | $92,691 |
| 2022 | 12 | 332 | 426 | $181,873 | $48,724 |
| 2021 | 9 | 486 | 715 | $216,170 | $65,467 |
| 2020 | 15 | 585 | 788 | $243,004 | $73,904 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 235 | $110,450 | $33,048 | 29.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 75 | 75 | $49,200 | $12,371 | 25.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 66 | $46,332 | $11,253 | 24.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $26,796 | $5,712 | 21.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 45 | $15,750 | $4,301 | 27.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $7,700 | $3,956 | 51.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 80 | 82 | $14,500 | $3,792 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 36 | $13,320 | $3,475 | 26.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 68 | 70 | $12,007 | $3,084 | 25.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 84 | 86 | $16,406 | $2,670 | 16.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 36 | $8,280 | $2,250 | 27.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 47 | 63 | $6,867 | $1,733 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $8,874 | $1,656 | 18.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $5,616 | $1,357 | 24.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 15 | $1,440 | $472.05 | 32.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 21 | 29 | $1,392 | $435.87 | 31.3% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 12 | 14 | $1,260 | $390.88 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 22 | $1,540 | $243.41 | 15.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 22 | $374.00 | $184.80 | 49.4% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 11 | 11 | $616.00 | $157.41 | 25.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 17 | 18 | $468.00 | $136.98 | 29.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 137 | $411.00 | $12.49 | 3.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 58 | 122 | $80,994 | $20,833 | 25.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $21,364 | $5,579 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 25 | $10,790 | $3,709 | 34.4% |
About Dr. Timur Graham, M.D
Dr. Timur Graham, M.D is a Pulmonary Disease healthcare provider based in Fall River, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1497933683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timur Graham, M.D has received a total of $5,469 in payments from pharmaceutical and medical device companies, with $2,507 received in 2024. These payments were reported across 259 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,410).
As a Medicare-enrolled provider, Graham has provided services to 2,200 Medicare beneficiaries, totaling 3,077 services with total Medicare billing of $280,787. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Fall River, MA
- Active Since 02/10/2008
- Last Updated 06/04/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1497933683
Products in Payments
- FASENRA (Biological) $959.43
- DUPIXENT (Biological) $494.39
- TEZSPIRE (Biological) $479.89
- NUCALA (Biological) $409.64
- TRELEGY ELLIPTA (Drug) $278.93
- XOLAIR (Drug) $273.14
- AIRSUPRA (Drug) $218.73
- OFEV (Drug) $196.80
- TYVASO (Drug) $181.58
- YUPELRI (Drug) $172.95
- STIOLTO RESPIMAT (Drug) $145.13
- AREXVY (Drug) $125.95
- Xolair (Biological) $117.42
- GLASSIA (Biological) $106.53
- FASENRA (Drug) $104.19
- BREZTRI (Drug) $102.45
- PREVNAR 20 (Biological) $78.03
- (8874) inCourage (Device) $68.82
- Yupelri (Drug) $48.56
- FLUZONE HIGH-DOSE (Biological) $46.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Fall River
Dr. Brendan Carolan, Md, MD
Pulmonary Disease — Payments: $10,587
Alejandro Lorenzana, M.d, M.D
Pulmonary Disease — Payments: $8,627
Daniel Sousa, Md, MD
Pulmonary Disease — Payments: $1,596
Dr. Lelia Lamp, M.d, M.D
Pulmonary Disease — Payments: $1,059
Dr. Nick Mucciardi, Md, MD
Pulmonary Disease — Payments: $973.88
Essam Awad, Md, MD
Pulmonary Disease — Payments: $648.52